Literature DB >> 23389502

Daily life physical activity in long-term survivors of nephroblastoma and neuroblastoma.

Marjolein van Waas1, Mark Wijnen, Annelies Hartman, Andrica C H de Vries, Rob Pieters, Sebastian J C M M Neggers, Marry M van den Heuvel-Eibrink.   

Abstract

The risk of metabolic late effects after childhood cancer, such as obesity, hypertension, and diabetes, can be positively influenced by a healthy lifestyle with sufficient physical activity. Nevertheless, studies on physical activity in adult survivors of childhood cancer are scarce and involve different and often nonvalidated questionnaires. We used the Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH), which was developed and validated to assess daily life physical activity in the Dutch adult population. The aim of the study was to assess daily life physical activity in Dutch adult long-term nephroblastoma and neuroblastoma survivors. Sixty-seven nephroblastoma and 36 neuroblastoma survivors (median age, 30 y; range, 18 to 51 y) and 60 sociodemographically similar healthy control subjects (median age, 32 y; range, 18 to 62 y) were asked to complete the SQUASH during their regular follow-up visit. The adjusted mean physical activity score in male neuroblastoma survivors (mean, 7155; P=0.004) was significantly lower than in male controls (mean, 10,574), whereas it was not significantly lower in male nephroblastoma survivors (mean, 9122; P=0.108). Adjusted means for physical activity scores in females were not different from their controls. In conclusions, male neuroblastoma survivors were identified as performing less daily physical activity.

Entities:  

Mesh:

Year:  2013        PMID: 23389502     DOI: 10.1097/MPH.0b013e31827e8fb9

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study.

Authors:  Danielle Novetsky Friedman; Patrick Hilden; Chaya S Moskowitz; Suzanne L Wolden; Emily S Tonorezos; Zoltan Antal; Dean Carlow; Shakeel Modak; Nai-Kong Cheung; Kevin C Oeffinger; Charles A Sklar
Journal:  Pediatr Blood Cancer       Date:  2018-07-15       Impact factor: 3.167

2.  Multi-Omics Integration Reveals a Competitive Endogenous RNAs Network for the Identification of Progression Biomarkers and the Stratification of Patients Diagnosed With Nephroblastoma.

Authors:  Jingbo Wang; Yuan Wang; Liang Han; Mohamed Shahen; Chaofeng Hu; Furong Li
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

Review 3.  Late Effects and Survivorship Issues in Patients with Neuroblastoma.

Authors:  Danielle Novetsky Friedman; Tara O Henderson
Journal:  Children (Basel)       Date:  2018-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.